Boniva and Movement - uncontrolled or slow - a phase IV clinical study of FDA data
Summary:
Movement - uncontrolled or slow is found among people who take Boniva, especially for people who are female, 50-59 old, have been taking the drug for 1 - 6 months.
The phase IV clinical study analyzes which people take Boniva and have Movement - uncontrolled or slow. It is created by eHealthMe based on reports of 26,532 people who have side effects when taking Boniva from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
26,532 people reported to have side effects when taking Boniva.
Among them, 24 people (0.09%) have Movement - uncontrolled or slow.
What is Boniva?
Boniva has active ingredients of ibandronate sodium. It is often used in osteoporosis. eHealthMe is studying from 26,915 Boniva users for its effectiveness, alternative drugs and more.
What is Movement - uncontrolled or slow?
Movement - uncontrolled or slow is found to be associated with 1,980 drugs and 1,620 conditions by eHealthMe.
Number of Boniva and Movement - uncontrolled or slow reports submitted per year:

Time on Boniva when people have Movement - uncontrolled or slow *:
- < 1 month: 0.0 %
- 1 - 6 months: 55 %
- 6 - 12 months: 0.0 %
- 1 - 2 years: 0.0 %
- 2 - 5 years: 45 %
- 5 - 10 years: 0.0 %
- 10+ years: 0.0 %
Gender of people who have Movement - uncontrolled or slow when taking Boniva *:
- female: 100 %
- male: 0.0 %
Age of people who have Movement - uncontrolled or slow when taking Boniva *:
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 0.0 %
- 30-39: 42.11 %
- 40-49: 0.0 %
- 50-59: 47.37 %
- 60+: 10.53 %
Common drugs people take besides Boniva *:
- Fosamax: 22 people, 91.67%
- Alendronate Sodium: 10 people, 41.67%
- Metoclopramide: 4 people, 16.67%
- Clonazepam: 3 people, 12.50%
- Lipitor: 2 people, 8.33%
- Clozapine: 2 people, 8.33%
- Bentyl: 2 people, 8.33%
- Prevacid: 2 people, 8.33%
- Colace: 2 people, 8.33%
- Bactrim: 2 people, 8.33%
Common side effects people have besides Movement - uncontrolled or slow *:
- Tooth Disorder (tooth disease): 18 people, 75.00%
- Adverse Event: 14 people, 58.33%
- Weakness: 13 people, 54.17%
- Constipation: 13 people, 54.17%
- Impaired Healing: 13 people, 54.17%
- Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 13 people, 54.17%
- Fall: 13 people, 54.17%
- Dizziness: 13 people, 54.17%
- Depression: 13 people, 54.17%
- Urinary Tract Infection: 13 people, 54.17%
Common conditions people have *:
- Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 2 people, 8.33%
- Swollen Tongue (swelling of tongue): 1 person, 4.17%
- Sleep Walking (walking during sleep): 1 person, 4.17%
- Schizophrenia (a mental disorder characterized by a breakdown of thought processes): 1 person, 4.17%
- Pharyngeal Oedema (abnormal accumulation of fluid in the cavities and intercellular spaces of the pharyngeal): 1 person, 4.17%
- Oedema Mouth (swelling of mouth): 1 person, 4.17%
- Lip Swelling: 1 person, 4.17%
- Indigestion: 1 person, 4.17%
- Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 1 person, 4.17%
- Hypersensitivity: 1 person, 4.17%
* Approximation only. Some reports may have incomplete information.
Do you take Boniva and have Movement - uncontrolled or slow?
Check whether Movement - uncontrolled or slow is associated with a drug or a conditionHow to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Related studies
How severe was Movement - uncontrolled or slow and when was it recovered:
Expand to all the drugs that have ingredients of ibandronate sodium:
Alternative drugs to, pros and cons of Boniva:
- Boniva (26,915 reports)
Common Boniva side effects:
- Joint pain: 2,663 reports
- Pain: 1,894 reports
- Back pain: 1,756 reports
- Diarrhea: 1,695 reports
Browse all side effects of Boniva:
a b c d e f g h i j k l m n o p q r s t u v w x y zMovement - uncontrolled or slow treatments and more:
- Movement - uncontrolled or slow (24,952 reports)
COVID vaccines that are related to Movement - uncontrolled or slow:
- Movement - uncontrolled or slow in Moderna COVID Vaccine
- Movement - uncontrolled or slow in Pfizer BioNTech Covid Vaccine
- Movement - uncontrolled or slow in Johnson and Johnson Covid Vaccine
Common drugs associated with Movement - uncontrolled or slow:
- Metoclopramide: 8,721 reports
- Clopra: 8,721 reports
- Reglan: 4,032 reports
- Abilify: 1,364 reports
- Risperidone: 1,253 reports
- Risperdal: 1,070 reports
- Zyprexa: 917 reports
- Aripiprazole: 874 reports
- Olanzapine: 873 reports
- Clozapine: 848 reports
All the drugs that are associated with Movement - uncontrolled or slow:
- Movement - uncontrolled or slow (1,980 drugs)
Common conditions associated with Movement - uncontrolled or slow:
- Indigestion: 2,628 reports
- Parkinson's disease: 1,347 reports
- Schizophrenia: 1,247 reports
- Depression: 964 reports
- Bipolar disorder: 552 reports
- Attention deficit hyperactivity disorder: 376 reports
All the conditions that are associated with Movement - uncontrolled or slow:
- Movement - uncontrolled or slow (1,620 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on ibandronate sodium (the active ingredients of Boniva) and Boniva (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Advair Diskus 250/50 and Musculoskeletal Pain - now
- Baclofen and Venlafaxine Hydrochloride drug interaction - now
- Psoriasis and Septic Shock - 4 seconds ago
- Euthyrox and Haemorrhoids - 7 seconds ago
- Nexplanon and Pain - 7 seconds ago
- Trimethoprim vs. Sulfamethoxazole And Trimethoprim Double Strength - 8 seconds ago
- Requip vs. Tramadol Hydrochloride - 12 seconds ago
- Fludrocortisone Acetate and Back Pain - 13 seconds ago
- Naprosyn and Cardiac Valve Disease - 13 seconds ago
- Nystatin and Infusion Site Bruising - 14 seconds ago